
Assay Blocking Blog calprotectin elisa Elisa hama antibodies hmgb1 elisa iron assay Isotype mobp antibody p24 elisa Pcr pge2 elisa plc gamma 2 tbars assay kit upp1 Vector
How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries
Richard
- 0
Coronavirus illness 2019 (COVID-19) introduced the world to its knees. As every nation grappled with launching an efficient response whereas concurrently minimizing repercussions on well being care techniques, economies, and societies, the medical and scientific panorama shifted perpetually.
Particularly, COVID-19 has challenged and remodeled the sphere of dermatology and the best way we observe. On this article, dermatologists from 11 nations share insights gained from native expertise. These international views will assist present a greater framework for delivering high quality dermatologic care and understanding how the sphere has advanced throughout this medical disaster.
Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Illness
Many pores and skin manifestations of extreme acute respiratory syndrome coronavirus-2 (SARS-CoV-2) an infection replicate activation of cutaneous and systemic immune responses involving effector pathways of each the innate and adaptive arms of the immune system.
This text evaluations proof from the current scientific and scientific literature that informs the present understanding of the implications of coronavirus illness 2019 (COVID-19)-induced immune cell activation, as related to dermatology. Subjects embody the scientific penalties of autoantibody manufacturing in sufferers with COVID-19, immunologic proof for chilblains as a manifestation of SARS-CoV-2 an infection, and the connection between kind I interferons and COVID-19 illness severity.
The consequences of Alzheimer’s and Parkinson’s illness on 28-day mortality of COVID-19
We in contrast the prognosis of inpatients with a recognized prognosis of Alzheimer’s or Parkinson’s illness who’ve COVID-19 an infection with different hospitalized sufferers with COVID-19. Our cohort research began in October 2020 and resulted in Could 2021 and included inpatients with COVID-19 an infection who have been admitted to hospitals.
From a complete of 67,871 sufferers with a confirmed prognosis of COVID-19, a pattern of 3732 people have been chosen of which 363 had Alzheimer’s, and 259 had Parkinson’s illness. All sufferers had each optimistic RT-PCR check and optimistic chest CT for COVID-19. The result was useless inside 28 days of admission and the predictors have been a lot of demographic and scientific options, and comorbidities recorded at sufferers’ bedside. Mortality have been 37.5%, 35.1%, and 29.5% in sufferers with Alzheimer’s illness, Parkinson’s illness; and in different sufferers, respectively.
The hazard ratio for Alzheimer’s illness was 1.27 (95% CI, 1.06-1.53, p=0.010) and for Parkinson’s illness was 1.17 (95% CI, 0.94-1.46, p=0.171). Age was a predictor of mortality, hazard ratio=1.04 (95% CI, 1.03-1.05, p<0.001). Sufferers with Alzheimer’s illness and COVID-19 an infection have been older and extra more likely to have a lack of consciousness on admission (each p≤0.001).
We concluded that inpatients with Alzheimer’s illness have an elevated danger for 28-day mortality from COVID-19 and healthcare settings needs to be prepared to supply vital take care of them akin to early intubation and fast O2 remedy. Nonetheless, Parkinson’s illness doesn’t considerably predict larger mortality of COVID-19.
Hormone remedy and cardiovascular illness: Advantages and harms
Menopause transition marks an vital section in life when cardiovascular danger in girls regularly takes an antagonistic flip. Though menopausal hormone remedy has gained a damaging appreciation during the last a long time, its worth within the remedy of disabling vasomotor signs continues to be undisputed. Cardiovascular danger evaluation has change into a matter of precision medication, which is useful for protected menopausal hormone remedy prescription. With a multidisciplinary strategy the present accessible hormone regimens will be even given to girls at intermediate cardiovascular danger, when danger elements akin to hypertension and dyslipidemia are adequately monitored and handled.
Publish-Transplant Cardiovascular Illness
Heart problems stays a number one reason behind demise and morbidity in kidney transplant recipients and a standard cause for post-transplant hospitalization. A number of conventional and nontraditional cardiovascular danger elements exist, and plenty of of them current pretransplant and worsened, partly, as a result of addition of immunosuppression post-transplant.
We talk about optimum methods for identification and remedy of those danger elements, together with the rising function of sodium-glucose cotransporter 2 inhibitors in post-transplant diabetes and heart problems. We current widespread sorts of heart problems noticed after kidney transplant, together with coronary artery illness, coronary heart failure, pulmonary hypertension, arrhythmia, and valvular illness.
We additionally talk about screening, remedy, and prevention of post-transplant cardiac illness. We spotlight areas of future analysis, together with the necessity for targets and greatest medicines for danger elements, the function of biomarkers, and the function of screening and intervention.
Coronavirus Illness 2019 and Dermatology Observe Modifications
The influence of the COVID-19 pandemic on dermatology observe can’t be overstated. At its peak, the pandemic resulted within the short-term closure of ambulatory websites as assets have been reallocated in direction of pandemic response efforts.
Many outpatient clinics have since reopened and are starting to expertise a semblance of pre-pandemic routine, albeit with restrictions in place. We offer an outline of how COVID-19 has affected dermatology observe globally starting with the rise of teledermatology. A abstract of knowledgeable suggestions that form the “new regular” in varied domains of dermatology observe, specifically, dermatology session, procedural dermatology, and phototherapy, can be supplied.
Power kidney illness measures for cardiovascular danger prediction
Power kidney illness (CKD) impacts 15-20% of adults globally and causes varied issues, some of the vital being heart problems (CVD). CKD has been related to many CVD subtypes, particularly extreme ones like coronary heart failure, unbiased of potential confounders akin to diabetes and hypertension.
There is no such thing as a consensus in main scientific tips as to how one can incorporate the 2 key measures of CKD (glomerular filtration price and albuminuria) for CVD danger prediction. It is a vital missed alternative to appropriately refine predicted danger and personalize prevention therapies in line with CKD standing, notably since these measures are sometimes already evaluated in scientific care.
![]() DSCAM Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV666683 | ABM | 1.0 ug DNA | EUR 3085 |
![]() DSCAM Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV666684 | ABM | 1.0 ug DNA | EUR 3085 |
![]() Dscam ORF Vector (Rat) (pORF) |
|||
ORF066231 | ABM | 1.0 ug DNA | EUR 2196 |
![]() DSCAM ORF Vector (Human) (pORF) |
|||
ORF018532 | ABM | 1.0 ug DNA | Ask for price |
![]() Dscam ORF Vector (Mouse) (pORF) |
|||
ORF043366 | ABM | 1.0 ug DNA | EUR 2196 |
![]() DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV723365 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-AS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV723369 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-AS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV723370 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV723371 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV723375 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV723376 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM Blocking Peptide |
|||
33R-6387 | Fitzgerald | 100 ug | EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DSCAM antibody, catalog no. 70R-6114 |
![]() DSCAM Polyclonal Antibody |
|||
ABP58424-003ml | Abbkine | 0.03ml | EUR 158 |
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein |
![]() DSCAM Polyclonal Antibody |
|||
ABP58424-01ml | Abbkine | 0.1ml | EUR 289 |
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein |
![]() DSCAM Polyclonal Antibody |
|||
ABP58424-02ml | Abbkine | 0.2ml | EUR 414 |
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein |
![]() DSCAM Polyclonal Antibody |
|||
A69471 | EpiGentek | 100 ?g | EUR 628.55 |
Description: The best epigenetics products |
![]() Anti-DSCAM antibody |
|||
STJ192190 | St John's Laboratory | 200 µl | EUR 197 |
Description: Unconjugated Rabbit polyclonal to DSCAM |
![]() DSCAM Polyclonal Antibody |
|||
ES11032-100ul | ELK Biotech | 100ul | EUR 279 |
Description: A Rabbit Polyclonal antibody against DSCAM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
![]() DSCAM Polyclonal Antibody |
|||
ES11032-50ul | ELK Biotech | 50ul | EUR 207 |
Description: A Rabbit Polyclonal antibody against DSCAM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
![]() Anti-DSCAM antibody |
|||
STJ70978 | St John's Laboratory | 100 µg | EUR 359 |
![]() DSCAM-AS1 ORF Vector (Human) (pORF) |
|||
ORF018533 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 ORF Vector (Human) (pORF) |
|||
ORF018534 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM ELISA KIT|Human |
|||
EF004874 | Lifescience Market | 96 Tests | EUR 689 |
![]() DSCAM Antibody, HRP conjugated |
|||
1-CSB-PA007192LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
![]() DSCAM Antibody, FITC conjugated |
|||
1-CSB-PA007192LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
![]() DSCAM Antibody, Biotin conjugated |
|||
1-CSB-PA007192LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
![]() Mouse Dscam ELISA KIT |
|||
ELI-47169m | Lifescience Market | 96 Tests | EUR 865 |
![]() Rat DSCAM shRNA Plasmid |
|||
20-abx987696 | Abbexa |
|
|
![]() Human DSCAM shRNA Plasmid |
|||
20-abx951275 | Abbexa |
|
|
![]() Mouse DSCAM shRNA Plasmid |
|||
20-abx970065 | Abbexa |
|
|
![]() DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV666680 | ABM | 1.0 ug DNA | EUR 3085 |
![]() DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV666681 | ABM | 1.0 ug DNA | EUR 3143 |
![]() DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV666682 | ABM | 1.0 ug DNA | EUR 3143 |
![]() DSCAM Protein Vector (Mouse) (pPB-C-His) |
|||
PV173462 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Mouse) (pPB-N-His) |
|||
PV173463 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Mouse) (pPM-C-HA) |
|||
PV173464 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Mouse) (pPM-C-His) |
|||
PV173465 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Rat) (pPB-C-His) |
|||
PV264922 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Rat) (pPB-N-His) |
|||
PV264923 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Rat) (pPM-C-HA) |
|||
PV264924 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Rat) (pPM-C-His) |
|||
PV264925 | ABM | 500 ng | EUR 3319 |
![]() DSCAM Protein Vector (Human) (pPB-C-His) |
|||
PV074125 | ABM | 500 ng | Ask for price |
![]() DSCAM Protein Vector (Human) (pPB-N-His) |
|||
PV074126 | ABM | 500 ng | Ask for price |
![]() DSCAM Protein Vector (Human) (pPM-C-HA) |
|||
PV074127 | ABM | 500 ng | Ask for price |
![]() DSCAM Protein Vector (Human) (pPM-C-His) |
|||
PV074128 | ABM | 500 ng | Ask for price |
![]() DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV723366 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV723367 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV723368 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV723372 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV723373 | ABM | 1.0 ug DNA | Ask for price |
![]() DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV723374 | ABM | 1.0 ug DNA | Ask for price |
![]() pECMV-Dscam-m-FLAG Plasmid |
|||
PVT15214 | Lifescience Market | 2 ug | EUR 325 |
![]() DSCAM Polyclonal Antibody, HRP Conjugated |
|||
A69472 | EpiGentek | 100 ?g | EUR 628.55 |
Description: kits suitable for this type of research |
![]() DSCAM Polyclonal Antibody, FITC Conjugated |
|||
A69473 | EpiGentek | 100 ?g | EUR 628.55 |
Description: fast delivery possible |
![]() DSCAM Polyclonal Antibody, Biotin Conjugated |
|||
A69474 | EpiGentek | 100 ?g | EUR 628.55 |
Description: reagents widely cited |
![]() Polyclonal Goat Anti-DSCAM Antibody |
|||
APG03359G | Leading Biology | 0.1 mg | EUR 484 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-DSCAM . This antibody is tested and proven to work in the following applications: |
![]() DSCAM-IT1 Protein Vector (Human) (pPB-C-His) |
|||
PV074133 | ABM | 500 ng | Ask for price |
![]() DSCAM-IT1 Protein Vector (Human) (pPB-N-His) |
|||
PV074134 | ABM | 500 ng | Ask for price |
![]() DSCAM-IT1 Protein Vector (Human) (pPM-C-HA) |
|||
PV074135 | ABM | 500 ng | Ask for price |
![]() DSCAM-IT1 Protein Vector (Human) (pPM-C-His) |
|||
PV074136 | ABM | 500 ng | Ask for price |
![]() DSCAM sgRNA CRISPR Lentivector set (Human) |
|||
K0633201 | ABM | 3 x 1.0 ug | EUR 339 |
![]() Dscam sgRNA CRISPR Lentivector set (Rat) |
|||
K7053401 | ABM | 3 x 1.0 ug | EUR 339 |
![]() Dscam sgRNA CRISPR Lentivector set (Mouse) |
|||
K3785001 | ABM | 3 x 1.0 ug | EUR 339 |
![]() DSCAM 3'UTR Luciferase Stable Cell Line |
|||
TU006333 | ABM | 1.0 ml | EUR 2333 |
![]() Dscam 3'UTR GFP Stable Cell Line |
|||
TU155400 | ABM | 1.0 ml | Ask for price |
![]() Dscam 3'UTR Luciferase Stable Cell Line |
|||
TU105400 | ABM | 1.0 ml | Ask for price |
![]() Dscam 3'UTR Luciferase Stable Cell Line |
|||
TU203644 | ABM | 1.0 ml | Ask for price |
![]() Dscam 3'UTR GFP Stable Cell Line |
|||
TU253644 | ABM | 1.0 ml | Ask for price |
![]() DSCAM 3'UTR GFP Stable Cell Line |
|||
TU056333 | ABM | 1.0 ml | EUR 2333 |
![]() DSCAM sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0633202 | ABM | 1.0 ug DNA | EUR 154 |
![]() DSCAM sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0633203 | ABM | 1.0 ug DNA | EUR 154 |
![]() DSCAM sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0633204 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7053402 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7053403 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7053404 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3785002 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3785003 | ABM | 1.0 ug DNA | EUR 154 |
![]() Dscam sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3785004 | ABM | 1.0 ug DNA | EUR 154 |
![]() Down Syndrome Cell Adhesion Molecule Homolog (DSCAM) Antibody |
|||
abx431217-200ul | Abbexa | 200 ul | EUR 384 |
![]() Down syndrome cell adhesion molecule homolog (DSCAM) Antibody |
|||
20-abx334273 | Abbexa |
|
|
![]() Human Down syndrome cell adhesion molecule, DSCAM ELISA KIT |
|||
ELI-09255h | Lifescience Market | 96 Tests | EUR 824 |
![]() Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (HRP) |
|||
20-abx335457 | Abbexa |
|
|
![]() Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (FITC) |
|||
20-abx335458 | Abbexa |
|
|
![]() Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (Biotin) |
|||
20-abx335459 | Abbexa |
|
|
![]() Human Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit |
|||
abx384809-96tests | Abbexa | 96 tests | EUR 911 |
![]() Mouse Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit |
|||
abx389101-96tests | Abbexa | 96 tests | EUR 911 |
![]() Rat Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit |
|||
abx391247-96tests | Abbexa | 96 tests | EUR 911 |
![]() Dscam ELISA Kit| Rat Down syndrome cell adhesion molecule homol |
|||
EF018602 | Lifescience Market | 96 Tests | EUR 689 |
![]() Dscam ELISA Kit| Mouse Down syndrome cell adhesion molecule hom |
|||
EF014731 | Lifescience Market | 96 Tests | EUR 689 |
![]() DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0633205 | ABM | 3 x 1.0 ug | EUR 376 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7053405 | ABM | 3 x 1.0 ug | EUR 376 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3785005 | ABM | 3 x 1.0 ug | EUR 376 |
![]() DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K0633206 | ABM | 1.0 ug DNA | EUR 167 |
![]() DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K0633207 | ABM | 1.0 ug DNA | EUR 167 |
![]() DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K0633208 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7053406 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7053407 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7053408 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3785006 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3785007 | ABM | 1.0 ug DNA | EUR 167 |
![]() Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3785008 | ABM | 1.0 ug DNA | EUR 167 |
![]() dCas9-KRAB Lentiviral Vector |
|||
K203 | ABM | 10 ug | EUR 228 |
![]() Cas9 Nuclease Lentiviral Vector |
|||
K002 | ABM | 10 ug | EUR 154 |
![]() Cas9 Nickase Lentiviral Vector |
|||
K005 | ABM | 10 ug | EUR 154 |
![]() pSMPUW-Puro Lentiviral Expression Vector |
|||
VPK-212 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-Neo Lentiviral Expression Vector |
|||
VPK-213 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-Hygro Lentiviral Expression Vector |
|||
VPK-214 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pLenti-GFP Lentiviral Control Vector |
|||
LTV-400 | Cell Biolabs | 100 µL | EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
![]() pSMPUW-MNDnLacZ Lentiviral Control Vector |
|||
LTV-402 | Cell Biolabs | 10 µg | EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
![]() ESR1 Lentiviral Vector (Human) (pLenti-II) |
|||
LV010008 | ABM | 1.0 ug DNA | EUR 316 |
![]() pSMPUW Universal Lentiviral Expression Vector (Promoterless) |
|||
VPK-211 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-IRES-Puro Lentiviral Expression Vector |
|||
VPK-215 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-IRES-Neo Lentiviral Expression Vector |
|||
VPK-216 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-IRES-Hygro Lentiviral Expression Vector |
|||
VPK-217 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-IRES-Blasticidin Lentiviral Expression Vector |
|||
VPK-219 | Cell Biolabs | 10 µg | EUR 624 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
![]() pSMPUW-GFP-Puro Lentiviral Control Vector |
|||
LTV-401 | Cell Biolabs | 10 µg | EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
![]() pLenti-RFP-Puro Lentiviral Control Vector |
|||
LTV-403 | Cell Biolabs | 100 µL | EUR 618 |
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus. |
![]() pSMPUW-GFP-LC3 Lentiviral Expression Vector |
|||
LTV-801 | Cell Biolabs | 10 µg | EUR 1204 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
![]() OR52B3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739168 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52B5P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739169 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52B5P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739173 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52B5P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739174 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739175 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739179 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739180 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E3P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739181 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739185 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739186 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E7P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739187 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E7P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739191 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52E7P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739192 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52H2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739193 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52H2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739197 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52H2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739198 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J1P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739199 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739203 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J1P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739204 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739205 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739209 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52J2P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739210 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52K3P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739211 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52K3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV739215 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52K3P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV739216 | ABM | 1.0 ug DNA | Ask for price |
![]() OR52L2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV739217 | ABM | 1.0 ug DNA | Ask for price |
On this overview, we offer an outline of CKD definition and staging, the subtypes of CVD most related to CKD, main pathophysiological mechanisms, and the present state of CKD as a predictor of CVD in main scientific tips. We are going to introduce the novel idea of a “CKD Add-on”, which permits the incorporation of CKD measures in current danger prediction fashions, and the implications of making an allowance for CKD within the administration of CVD danger.
Tags: actin polymerization assay anti beta galactosidase antibody anti flag antibody biotin conjugation kit c jun antibody caspase 1 assay cell separation colorimetric western blot cxcl12 antibody deoxyribonuclease i dolichos biflorus agglutinin elisa array empty chromatography columns endotoxin removal buffer hot start taq dna polymerase how much protein to load for western blot ldlr antibody omega rna extraction kit pcr enhancer pcr plate sealer pdgfr alpha antibody qpcr array tubulin western blot vglut2 antibody western blot alternatives western blot kits western blotting antibodies western blotting machine western blotting membranes western blotting reagents